Abstract
The growth factor midkine (MK) is a cytokine that inhibits HIV infection in cell cultures in an autocrine and paracrine manner by blocking the attachment of HIV particles to permissive cells. MK mRNA is systematically expressed in adult peripheral blood lymphocytes from healthy donors, while its expression becomes markedly but transiently increased upon in vitro treatment of lymphocytes with IL-2 or IFN-γ and activation of T lymphocytes by PHA or through the engagement of the CD28 antigen. The binding of MK to cells occurs specifically at a high and a low affinity binding site. This low affinity-binding site is the cell-surface expressed nucleolin, which is implicated in the mechanism of the initial attachment of HIV particles to cells. Accordingly, the nucleolin-binding HB-19 pseudopeptide has no effect on the MK binding to the high affinity binding site, whereas it prevents the binding of MK to the low affinity binding site, thus suggesting the low affinity receptor of MK is the cell-surface-expressed nucleolin. Confocal immunofluorescence laser microscopy revealed the colocalization of MK and the cell-surface-expressed nucleolin at distinct spots. The use of various deletion constructs of nucleolin then indicates that the extreme C-terminal end of nucleolin, containing repeats of the amino acid motif RGG, as the domain that binds MK. The specific binding of MK to the surface nucleolin is independent of heparan sulfate and chondroitin sulfate proteoglycans. After binding to cells, MK enters cells by an active process in which nucleolin and lipid rafts appear to be implicated. The potent and the distinct anti-HIV action of MK along with its enhanced expression in lymphocytes by various physiological stimuli, point out that MK is a cytokine that could be involved in HIV pathogenesis.
Similar content being viewed by others
Log in or create a free account to read this content
Gain free access to this article, as well as selected content from this journal and more on nature.com
or
References
Nisole S, Krust B, Callebaut C, et al. The anti-HIV pseudopeptide HB-19 forms a complex with the cell-surface expressed nucleolin independent of heparan sulfate proteoglycans. J Biol Chem 1999; 274:27875–84.
Nisole S, Krust B, Dam E, et al. The HB-19 pseudopeptide 5[Ky(CH2N)PR]-TASP inhibits attachment of T-lymphocyte- and macrophage-tropic HIV to permissive cells., AIDS Res Hum Retroviruses 2000; 16:237–49.
Callebaut C, Nisole S, Briand JP, Krust B, Hovanessian AG . Inhibition of HIV infection by the cytokine midkine. Virology 2001; 281:248–64.
Said AE, Krust B, Nisole S, Briand JP, Hovanessian AG . The anti-HIV cytokine midkine binds the cell-surface-expressed nucleolin as a low affinity receptor, J Biol Chem 2002; 277:37492–502.
Said EA, Courty J, Svab J, et al. Pleiotrophin inhibits HIV infection by binding the cell surface expressed nucleolin. FEBS J 2005; 272:4646–59.
Legrand D, Vigie K, Said EA, et al. Surface nucleolin participates in both the binding and endocytosis of lactoferrin in target cells. Eur J Biochem 2004; 271:303–17.
Kurtz A, Schulte AM, Wellstein A . Pleiotrophin and midkine in normal development and tumor biology. Crit Rev Oncog 1995; 6:151–77.
Muramatsu T . The midkine family of growth differentiation factors. Dev Growth Differ 1994; 36:1–8.
Kadomatsu K, Muramatsu T . Midkine and pleiotrophin in neural development and cancer. Cancer Lett 2004; 204:127–43.
Ginisty H, Sicard H, Roger B, Bouvet P . Structure and functions of nucleolin. J Cell Science 1999; 112:761–72.
Srivastava M, Pollard, HB . Molecular dissection of nucleolin's role in growth and cell proliferation: new insights. FASEB J 1999; 13:1911–22.
Hovanessian AG, Puvion-Dutilleul F, Nisole S, et al. The cell-surface-expressed nucleolin is associated with the actin cytoskeleton. Exp Cell Res 2000; 261:312–28.
Callebaut C, Jacotot E, Guichard G, et al. Inhibition of HIV infection by pseudopeptides blocking viral envelope glycoprotein-mediated membrane fusion and cell death. Virology 1996; 218:181–192.
Callebaut C, Jacotot E, Krust B, et al. Pseudopeptides TASP inhibitors of HIV infection block viral entry by binding to a 95 kDa cell surface protein. J Biol Chem 1997; 272:7159–66.
Callebaut C, Blanco J, Benkirane N, et al. Identification of V3 loop-binding proteins as potential receptors implicated in the binding of HIV particles to CD4+ cells. J Biol Chem 1998; 273:21988–97.
Nisole S, Krust B, Hovanessian AG . Anchorage of HIV on permissive cells leads to co-aggregation of viral particles with surface nucleolin at membrane raft microdomains. Exp Cell Res 2002; 276:155–73.
Nisole S, Said EA, Mische C, et al. The anti-HIV pentameric pseudopeptide HB-19 binds the C-terminal end of nucleolin and prevents anchorage of virus particles in the plasma membrane of target cells. J Biol Chem 2002; 277:20877–86.
Christian S, Pilch J, Akerman ME, et al. Nucleolin expressed at the cell surface is a marker of endothelial cells in angiogenic blood vessels. J Cell Biol 2003; 163:871–8.
Ye J, Young HA . Negative regulation of cytokine gene transcription. FASEB J 1997; 11:825–33.
Zou K, Muramatsu H, Ikematsu S, et al. A heparin-binding growth factor, midkine, binds to chondroitin sulfate proteoglycan, PG-M/versican. Eur J Biochem 2000; 267:4046–53.
Esko JD, Rostand KS, Weinke JL . Tumor formation dependent on proteoglycan biosynthesis. Science 1988; 241:1092–6.
Roghani M, Moscatelli D . Basic fibroblast growth factor is internalized through both receptor-mediated and heparan sulfate-mediated mechanisms. J Biol Chem 1992; 267:22156–62.
Yancey PG, Rodrigueza WV, Kilsdonk EP, et al. Cellular cholesterol efflux mediated by cyclodextrins. Demonstration of kinetic pools and mechanism of efflux. J Biol Chem 1996; 271:16026–34.
Shibata Y, Muramatsu T, Hirai M, et al. Nuclear targeting by the growth factor midkine. Mol Cell Biol 2002; 22:6788–96.
Civil A, Bakker A, Rensink I, et al. Nuclear appearance of a factor that binds the CD28 response element within the interleukin-2 enhancer correlates with interleukin-2 production. J Biol Chem 1996; 271:8321–7.
Ott M, Emiliani S, Van Lint C, et al. Immune hyperactivation of HIV-1 infected T cells mediated by Tat and the CD28 pathway. Science 1997; 275:1481–5.
Pantaleo G, Graziosi C, Fauci AS . New concepts in the immunopathogenesis of human immunodeficiency virus infection. N Engl J Med 1993; 328:327–35.
Acknowledgements
The members of the laboratory of Ara Hovanessian who contributed to this work are Christian Callebaut, Sebastien Nisole, Elias Said, Josette Svab, and Bernard Krust. The work was supported by grants from CNRS (Centre National de la Recherche Scientifique) et ANRS (Agence Nationale de la Recherche sur le SIDA), France.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Hovanessian, A. Midkine, a cytokine that inhibits HIV infection by binding to the cell surface expressed nucleolin. Cell Res 16, 174–181 (2006). https://doi.org/10.1038/sj.cr.7310024
Published:
Issue date:
DOI: https://doi.org/10.1038/sj.cr.7310024
Keywords
This article is cited by
-
Midkine (MDK) growth factor: a key player in cancer progression and a promising therapeutic target
Oncogene (2020)
-
Targeting surface nucleolin induces autophagy-dependent cell death in pancreatic cancer via AMPK activation
Oncogene (2019)
-
Targeting nucleolin for better survival in diffuse large B-cell lymphoma
Leukemia (2018)
-
RETRACTED ARTICLE: Nuclear Protein C23 on the Cell Surface Plays an Important Role in Activation of CXCR4 Signaling in Glioblastoma
Molecular Neurobiology (2015)
-
C23 protein meditates bone morphogenetic protein-2-mediated EMT via up-regulation of Erk1/2 and Akt in gastric cancer
Medical Oncology (2015)
